EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Understanding PPARγ and Its Agonists on Trophoblast Differentiation and Invasion: Potential Therapeutic Targets for Gestational Diabetes Mellitus and Preeclampsia

Yushu Qin iD, Donalyn Bily, Makayla Aguirre, Ke Zhang, Linglin Xie

Nutrients · 2023

DOI: 10.3390/nu15112459 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2023. Verfasst von Yushu Qin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Texas A&M University, College Station, TX 77843, USA. Hauptthemen laut MEDLINE: Diabetes, Gestational, Pre-Eclampsia, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, the National Institute of Environmental Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing incidence of pregnancy complications, particularly gestational diabetes mellitus (GDM) and preeclampsia (PE), is a cause for concern, as they can result in serious health consequences for both mothers and infants. The pathogenesis of these complications is still not fully understood, although it is known that the pathologic placenta plays a crucial role. Studies have shown that PPARγ, a transcription factor involved in glucose and lipid metabolism, may have a critical role in the etiology of these complications. While PPARγ agonists are FDA-approved drugs for Type 2 Diabetes Mellitus, their safety during pregnancy is not yet established. Nevertheless, there is growing evidence for the therapeutic potential of PPARγ in the treatment of PE using mouse models and in cell cultures. This review aims to summarize the current understanding of the mechanism of PPARγ in placental pathophysiology and to explore the possibility of using PPARγ ligands as a treatment option for pregnancy complications. Overall, this topic is of great significance for improving maternal and fetal health outcomes and warrants further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalPre-EclampsiaDiabetes Mellitus, Type 2HumansAnimalsMicePregnancyFemaleTrophoblastsPPAR gammaPlacentaCell Differentiation

Stichwörter der Autor:innen

PPARγgestational diabetes mellitusplacentapreeclampsiapregnancyrosiglitazonetrophoblast

Substanzen

PPAR gamma

Autor:innen und Institutionen

  • Department of Nutrition, Texas A&M University, College Station, TX 77843, USA.
  • Department of Biology, Texas A&M University, College Station, TX 77843, USA.
  • Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA.

ORCID-Profile: Yushu Qin

Förderung

  • NIEHS NIH HHS
  • the National Institute of Environmental Health Sciences

Zitieren

APA

Qin, Y., Bily, D., Aguirre, M., Zhang, K., & Xie, L. (2023). Understanding PPARγ and Its Agonists on Trophoblast Differentiation and Invasion: Potential Therapeutic Targets for Gestational Diabetes Mellitus and Preeclampsia. Nutrients. https://doi.org/10.3390/nu15112459

Vancouver

Qin Y, Bily D, Aguirre M, Zhang K, Xie L. Understanding PPARγ and Its Agonists on Trophoblast Differentiation and Invasion: Potential Therapeutic Targets for Gestational Diabetes Mellitus and Preeclampsia. Nutrients. 2023. doi:10.3390/nu15112459

BibTeX
@article{Qin2023,
  author = {Qin, Yushu and Bily, Donalyn and Aguirre, Makayla and Zhang, Ke and Xie, Linglin},
  title = {Understanding PPARγ and Its Agonists on Trophoblast Differentiation and Invasion: Potential Therapeutic Targets for Gestational Diabetes Mellitus and Preeclampsia},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15112459}
}
Kostenlos starten →